Exploration of the potential of the enterokine Fibroblast Growth Factor 19 (FGF19) as an anti-osteosarcopenic agent in murine preclinical models

Hao Zhang

Open source

DOI
10.70675/2cc53046z9908z4341zab05z96f684d7484a
Published
2025-07-03
Container
Not recorded
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.70675/2cc53046z9908z4341zab05z96f684d7484a,
  title = {Exploration of the potential of the enterokine Fibroblast Growth Factor 19 (FGF19) as an anti-osteosarcopenic agent in murine preclinical models},
  author = {Hao Zhang},
  year = {2025},
  doi = {10.70675/2cc53046z9908z4341zab05z96f684d7484a},
  url = {https://doi.org/10.70675/2cc53046z9908z4341zab05z96f684d7484a}
}

RIS

TY  - JOUR
TI  - Exploration of the potential of the enterokine Fibroblast Growth Factor 19 (FGF19) as an anti-osteosarcopenic agent in murine preclinical models
AU  - Hao Zhang
PY  - 2025
DO  - 10.70675/2cc53046z9908z4341zab05z96f684d7484a
UR  - https://doi.org/10.70675/2cc53046z9908z4341zab05z96f684d7484a
ER  - 

APA

Zhang, H. (2025). Exploration of the potential of the enterokine Fibroblast Growth Factor 19 (FGF19) as an anti-osteosarcopenic agent in murine preclinical models. https://doi.org/10.70675/2cc53046z9908z4341zab05z96f684d7484a

Source records